The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
Barley genome will help crop adapt to climate change and improve malting for beer – ABC Local
Posted: April 19, 2017 at 9:37 am
Posted April 19, 2017 19:24:35
Australian researchers have played a pivotal role in a global project to map the barley genome.
Ten countries have spent a decade working on the genome project, which forms the basis for working out which genes control certain traits in the barley plant.
West Australian scientists from Murdoch University and the Department of Agriculture and Food of WA led the Australian research, with funding assistance from the Grains Research and Development Corporation (GRDC).
Lead researcher and Murdoch University Professor Chengdao Li said a better understanding of the barley genome would help the development of plants adapted for climate change.
But Professor Li said the genome map would also help improve the traits important in using malted barley for beer.
He said barley was a historically important crop because of its special "brewing genes".
"People believe human beings started to use the malt in the barley in the Stone Ages to make alcoholic beverages," he said.
"That's why [humans] started the plant cultivation process so long ago."
Scientists have previously mapped the rice genome, but Professor Li said it the barley genome was far more complicated.
He said Australian researchers had played such a significant role in mapping the barley genome because, along with wheat, it was such a significant crop for Australian farmers.
Barley exports are worth just under $1 billion to the West Australian economy with forty per cent of exports destined for malting, mainly for use in beer.
Department of Agriculture and Food principal scientist Dr Rob Loughman said mapping the barley genome would ultimately pave the way for better plant breeding.
Dr Loughman said improved breeding would provide marketing opportunities, but he said the main reason for breeding better plants would be to serve the growers.
"Farmers are certainly familiar with the importance of combining agronomic improvement with genetic improvement from new varieties," he said.
"The sorts of characteristics they look for are things that enhance productivity and yield, things that get their products into target markets and things that mitigate risks in cropping."
Dr Loughman said improved adaptability to climate change would be the most significant gain for farmers.
Topics: grain, genetics, research, research-organisations, perth-6000
Read the original:
Barley genome will help crop adapt to climate change and improve malting for beer - ABC Local
Posted in Genome
Comments Off on Barley genome will help crop adapt to climate change and improve malting for beer – ABC Local
Bread Wheat Genome: Researchers Develop More Accurate Navigation System – FoodIngredientsFirst
Posted: at 9:36 am
19 Apr 2017 --- Scientists have created the most accurate navigation system for the bread wheat genome to date allowing academics and breeders to analyze its genes more easily than ever before.
Wheat is one of the world's most important staple cereals but is also the most complex. Three sub-genomes together contain around five times more DNA than the human genome. Nearly 80% of this genetic material is repetitive, making it even harder to sequence and analyze.
Now, harnessing advanced sequencing technology and computational approaches, scientists from the Earlham Institute, with colleagues at the John Innes Centre, have published the world's most complete picture of the wheat genome. It includes the location and detailed annotation of over 100,000 wheat genes. More than a fifth (22%) of these were completely absent from earlier assemblies, or found only as fragments.
"We applied the latest sequencing and bioinformatic techniques we have developed at our institute to the huge and complex wheat genome. We were able to achieve the best results anyone had seen, including uncovering previously hidden genes," says senior author Matthew Clark, Head of Technology Development at the Earlham Institute (EI).
"Moreover, all our methods are open, and available for anyone to use. This is critical as wheat DNA varies across the world, which is key to its success in different environments. We have already started to sequence many varieties of UK wheat using these methods, and we hope others will sequence the genomes of wheat important in their country," he says.
The results, published in Genome Research, focus on the variety called Chinese Spring -- the standard cultivar for genomic research. The genome and annotation have been accessed more than any other resource on the genomic portal Plant Ensembl , where they have been available for a over year for thousands of researchers and breeders to use. The project was funded by Biotechnology and Biological Sciences Research council grants to EI, John Innes Centre (JIC), European Bioinformatics Institute and Rothamsted Research, with contributions from international partners at the PSGB (Munich, Germany) and University Of Western Australia.
The improved genome assembly combined with high quality sequencing data and novel methods allowed EI scientists to more accurately identify genes and areas of the genome with interesting functions. In previous assemblies, many genes were missing or found only as fragments. By identifying the entire DNA sequences of genes, EI scientists have made it possible to identify more complete sets of similar genes -- called gene families -- that are important for yield, disease resistance or other qualities important for agriculture.
EI scientists have already used the advances to explore UK varieties and they have released six wheat genomes on the EI's open data website Grassroots Genomics. They and scientists from the John Innes Centre and The Sainsbury Laboratory have also started to use the results to provide a more accurate picture of where to find disease resistance genes and genes important for the visco-elastic properties of bread - which make it soft and spongy.
More than two billion people worldwide rely on wheat as a staple food, making it a vital crop for global food security. However, yield increases have stagnated since the mid-1990s. A better map of the wheat genome is essential for breaking the deadlock. It will help reveal the location of important traits that can be bred into elite varieties.
Lead author Bernardo Clavijo from the Earlham Institute says: "Scientists all over the world are already using these new results. But even more importantly, our open methods allow a new level of accuracy for any wheat line, and many other complex genomes. Assembly for this complexity of genome has always been a bit of a one-off work of art. Now we have a way to do it reliably and to a standard that enables thorough analysis."
"We are moving towards a scenario where more and more wheat lines will be sequenced and compared using these and similar techniques. This kind of detail on every wheat line will enable new discoveries and accelerate breeding. We are already working with the breeding industry as well as other researchers to enable more detailed analysis of elite varieties, which will impact the wheat breeding programs directly."
Ksenia Krasileva, a co-author on the new study, likens the creation of an assembly to navigating using GPS: "Breeders might know there is something really useful in wheat, for example for protecting crops against disease or for improving gluten for bread-making, but without a good quality genome assembly it's like driving through thick fog. Full genome assembly and annotating genes provides a sat nav view of wheat genes to signpost the way to useful genes in all varieties of the species."
EI group leader David Swarbreck says: "This is the most comprehensive wheat gene annotation to date, it represents a significant advance that will assist wheat breeders and researchers in accelerating further improvements, particularly as the results are freely available for anyone to use."
Co-author Michael Bevan from the John Innes Centre says: "The new resources we have helped develop have already broken down barriers and are providing new ways of studying wheat. They will allow breeders to more accurately predict which lines to breed from, and to directly identify the most promising progeny. This could save years when making new varieties."
Business News
19 Apr 2017 --- As British MPs prepare to vote on Prime Minister Theresa Mays call for a June 8 general election later today, the food and farming industries are urging the UK government to support the sectors which are vital to the UK economy.Mays snap call for a general election is due to be backed by MPs this afternoon, so the UK government can make a success of Brexit and focus on negotiating the best deals as the country exits the European Union.
Business News
19 Apr 2017 --- Mondelez International is shaking up its leadership with the announcement that executive vice president of North America Roberto Marques is leaving his role and Tim Cofer will step in as interim president adding to his current role spearheading the companys global growth strategy.
Business News
19 Apr 2017 --- What happens when meat scientists get their hands on nearly 8,000 commercially raised pigs? They spend a year running dozens of tests and crunching numbers to arrive at research-backed management recommendations for pork producers.
Business News
18 Apr 2017 --- The UKs iconic cereal brand Weetabix is reportedly being swallowed up by US Post Holdings in a 1.4 billion (US$1.7 million) deal. Chinese owners, The Bright Group, took a 60% share in Weetabix in May 2012 with Baring Private Equity Asia acquiring the remaining 40% from Lion Capital in 2015.
Food Ingredients News
18 Apr 2017 --- Texture makes foods and beverages vividly memorable and enjoyable. It's in line with taste in defining the eating and drinking experience. Ingredion has more than 60 years experience in texturizing food and beverages. The companys' extensive product portfolio offers a wide choice of texturizing ingredients, including base viscosifiers and co-texturizers, as well as gelling, crisping and pulping agents all are used to create different textures and claims.
Read more:
Bread Wheat Genome: Researchers Develop More Accurate Navigation System - FoodIngredientsFirst
Posted in Genome
Comments Off on Bread Wheat Genome: Researchers Develop More Accurate Navigation System – FoodIngredientsFirst
Cow genome map set to improve Brahman breed – ABC Online
Posted: at 9:36 am
Posted April 18, 2017 07:41:19
She is not the prettiest cow you have ever seen, but she is becoming one of the most important Brahmans in the business.
Elrose Naomi 3492 was 14 years old and had had eight calves when she made the ultimate sacrifice for science.
Now her lung tissue sits in a freezer as the final touches are put on a million-dollar project to sequence her genome.
She is not the first cow to have her DNA pulled apart and its order identified, but she will be the first Brahman, a tropically adapted breed found in Australia's north.
Eight years ago, the DNA of a Hereford cow called Dominette was unpacked and scrutinised by a team of international researchers at a cost of $US52 million.
Now, amid huge technological advances and for a fraction of that cost, Queensland researchers are keen to know more about what makes the northern cattle tick and, more importantly, how to improve it.
It is all part of a project to understand how genes from temperate cattle have influenced important production traits in the modern Brahman breed.
Professor Steve Moore, from the Centre for Animal Sciences, is director of the Queensland Alliance for Agriculture and Food Innovation (QAAFI).
He said northern cattle were not as productive as their southern Bos taurus counterparts.
"Their meat quality is not as good and their meat quality is penalised under MSA [Meat Standards Australia] if they have a hump," he said.
"We have to turn that around. We want to raise the value of the northern herd."
The Sequencing the Legends project, jointly funded by the Department of Agriculture and the University of Queensland, has resulted in the DNA of 50 top Brahman bulls picked apart and sequenced, with genes associated with specific traits being studied.
"We are unpacking the entire DNA sequences of 50 influential animals, then honing in on the genes associated with specific traits in order to capture the best genetics in the Brahman breed," Professor Moore said.
Brahmans are adapted to tropical climates, and there have been more than 300,000 years of separation between Bos indicus cattle such as Brahman and the Bos taurus cattle breeds that are important to temperate production systems.
Up until now, much of the world's genetics research has surrounded the Bos taurus, hence the sequencing of Hereford cow Dominette.
But Professor Moore said understanding the genetics underlying production traits in Australian tropically adapted cattle was essential for further breed development and crossbreeding strategies.
"We hope to improve the predictions and that will be delivered via something like Breedplan," he said.
"We will identify some of the mutations underlying some of the traits, but we're confounded by the fact we're working with the Bos taurus reference genome assembly and we get ambiguous results."
And that is where Elrose Namoi comes in.
Once her complete DNA sequence has been determined, she will become a reference animal for the Brahman breed, allowing the DNA of sequenced Brahman bulls to be "put back together" more accurately.
"We sequence a cow because a cow doesn't have a Y chromosome," Professor Moore said.
"The Y chromosome is a pain, so we try to avoid it. She's got two X chromosomes, which makes the X chromosome easier to assemble.
"Once we have Elrose Naomi sequenced, we'll be able to map those bulls onto the Brahman reference, so we'll hopefully have a complete picture of the majority of the Brahman population in Australia."
Professor Moore said for Australia to remain competitive, the industry had to do better with the animals it had in terms of markets, and that meant quality and productivity.
He said producers would start reaping the benefits of the genomics project through Breedplan within a "couple of years".
Topics: rural, cloning-and-dna, dna, beef-cattle, university-of-queensland-4072
Continue reading here:
Cow genome map set to improve Brahman breed - ABC Online
Posted in Genome
Comments Off on Cow genome map set to improve Brahman breed – ABC Online
Adam and the Genome Part Two – Patheos (blog)
Posted: at 9:36 am
Perhaps it will be well if I first state a few personal disclaimers. I have: 1) no problem with the idea that different areas of knowledge require different methodologies to arrive at theories that explain the facts; 2) also no problem with the usual observation that the Bible is not a scientific textbook, it does not teach cosmology, biology, anthropology, geology etc. 3) no problem with the observation that a proper critique of modern science cannot rest solely on pointing out gaps in the fossil record, or the lack of positive evidence for missing link creatures to connect critter A to critter B through evolutionary processes; 4) also no problem with the notion that a species can adapt and change as its environment changes over time, indeed being effected by the environment. In other words, I have no issues with micro-evolution within a species; and finally 5) I have no problem with the notion of a very old earth and a long pre-history before human kind created in Gods image shows up on planet earth. Genesis 1 is a piece of Hebrew poetry that demonstrates the divine origins and design of it all. It does not tell us how long it took to accomplish the process, nor does it fill in all the blanks along the way. In a broad sense, in any case, it comports with evolutionary ideas about human beings being the apex and most complex of all living things.
On the other hand, what is a problem with science is an assumption that one can globalize a scientific theory to be all encompassing, even impinging on areas outside the discipline of genetics, areas such as history and theology. What I mean by that is that the presuppositions of modern science are purely naturalistic or better said materialistic. All things can be explained if we just figure out the natural processes which produced these facts, and then connect the dots.
The problem with this is of course it assumes that God, at least in these spheres, only works by natural processes. It rules out miracles a priori. For example, it takes for granted that when you find common physical features in a whale and in a tetrapod that is a purely land-based creature, there must be a link and a transition between A and B. This leads to the quite proper question If God is the CEO and director of all creation (not merely the one who fired the starter gun, having provided the raw materials for the human race and other creatures) why in the world could God not simply use some of the same features in two different species of creatures? No reason is given. Why for example is it not possible that God decided fish would have vertebrae and at least front limbs, and so would humans without any necessary connection between these species? These differing types of creatures could have each developed along their own natural lines, but shared some features in common with other species. Genetic similarities do not necessarily lead to the conclusion of genetic connections.
The real problem here is when science impinges on human history, not animal history. The Bible may not teach science, but it certainly teaches some specific things about human history, as we shall see in this review.
Continued here:
Adam and the Genome Part Two - Patheos (blog)
Posted in Genome
Comments Off on Adam and the Genome Part Two – Patheos (blog)
Human Genome Project leader and NIH director set to speak at 102nd SMU Commencement – The Daily Campus
Posted: at 9:36 am
Francis S. Collins, M.D., Ph.D., director of the National Institutes of Health since 2009 and spearhead of the Human Genome Project (HGP), is scheduled to speak at SMUs 102nd Commencement on Saturday May 20 in Moody Coliseum.
Collins career has been all but lackluster. His own personal research has led to the isolation of genes causing cystic fibrosis, neurofibromatosis, Huntingtons disease, and Hutchinson-Gilford progeria syndrome. During his tenure as director of NIHs National Human Genome Research Institute, Collins oversaw the 13-year international collaborative effort to map and sequence James Watson and Francis Cricks double helix structure of DNA, with the conclusion of the project in 2003 coinciding with the 50th anniversary of Watson and Cricks seminal publication.
Overseeing what remains the worlds largest collaborative biological projectspossibly the most significant scientific undertaking in modern historyis only one aspect of Collins impressive resume. Appointed by President Obama and asked by Trump to remain in his position, Collins has launched groundbreaking research into increasing our understanding of neural brain networks to improve treatments for brain diseases, and has attempted to advance the use of precision medicine in hopes for more individually tailored healthcare.
The Virginia native earned his Bachelor of Science from the University of Virginia, Ph.D. from Yale University and an M.D. from the University of North Carolina at Chapel Hill.
Collins has received various awards, including the Presidential Medal of Freedom and the National Medal of Science. He will soon receive a Doctor of Science degree from SMU during the Commencement ceremony.
An elected member of the Institute of Medicine and the National Academy of Sciences, Collins has valuable insight to share with SMUs soon-to-be graduates.
Read more from the original source:
Human Genome Project leader and NIH director set to speak at 102nd SMU Commencement - The Daily Campus
Posted in Genome
Comments Off on Human Genome Project leader and NIH director set to speak at 102nd SMU Commencement – The Daily Campus
Gene salad: First comprehensive genome assembly of lettuce reveals ‘treasure-trove of genetic information’ – Genetic Literacy Project
Posted: at 9:36 am
UC Davis researchers announced inNature Communicationsthat they have unlocked a treasure-trove of genetic information about lettuce and related plants, releasing the first comprehensive genome assembly for lettuce and the hugeCompositaeplant family.
With an annual on-farm value of more than $2.4 billion, it is the most valuable fresh vegetable and one of the 10 most valuable crops, overall, in the United States.
The genome assembly a compilation of millions of DNA sequences into a useful genetic portrait provides researchers with a valuable tool for exploringCompositaefamilys many related plant species.
This genome assembly provides the foundation for numerous further genetic, evolutionary and functional studies of this whole family of plants, said Reyes-Chin-Wo, the lead author and graduate student in thelaboratoryof plant geneticist Richard Michelmore.
This is particularly significant becauseCompositaeis the most successful family of flowering plants on earth in terms of the number of species and environments inhabited, said Richard Michelmore, who directs the UC Davis Genome Center.
[Read the full study here]
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Gene Salad: Lettuce Genome Assembly Published
For more background on the Genetic Literacy Project, read GLP on Wikipedia
Read more here:
Gene salad: First comprehensive genome assembly of lettuce reveals 'treasure-trove of genetic information' - Genetic Literacy Project
Posted in Genome
Comments Off on Gene salad: First comprehensive genome assembly of lettuce reveals ‘treasure-trove of genetic information’ – Genetic Literacy Project
National Garlic Day – AgNet West
Posted: at 9:36 am
April 19th, is National Garlic Day.Cathy Isom tells you how you may pay homage to a stinky vegetable that is also known as natures wonder drug.Thats coming up on This Land of Ours.
Garlic, which is dubbed the Stinking Rose because of its overpowering taste and smell,dates back more than 6,000 years ago. Its a member of the Lily family, which also includes onions, leeks and shallots. Its great in many culinary cuisines. But its also known for its wide-reaching medicinal properties in treating illness and disease. Garlic are rich in protein, Vitamin A, B-1 and C and contains essential minerals such as calcium, magnesium and iron. The U.S. is the 6th top producer of garlic in the world. With much of its supply coming out of Gilroy, California, a town about an hour southeast of San Francisco, known as the self-proclaimed as the Garlic Capital of the World. Will Rogers was once quoted as saying it is the only place in America where you can marinate a steak just by hanging it out on a clothes line.
Im Cathy Isom
From: National Garlic Day
Regarded as a force of both good and evil, the Egyptians are said to have fed the herb to workers building the Great Pyramid of Giza because they believed it boosted their stamina. In the Middle Ages, plague-phobic Europeans ate whole cloves of garlic to fight off the scourge known as the Black Death.
The herb, which can also be deemed a vegetable too, is rich in protein, vitamins A, B-1 and C and contains essential minerals such as calcium, magnesium and iron. It also contains 17 different amino acids.
Posted in Human Longevity
Comments Off on National Garlic Day – AgNet West
Eli Lilly and Company: New Report Reveals Little Progress on 2014 WHO Psoriasis Recommendations – Yahoo Finance
Posted: at 9:35 am
TORONTO--(BUSINESS WIRE)--
A new report by the Economist Intelligence Unit (EIU) challenges policymakers and healthcare professionals to address the burden of psoriasis, a chronic autoimmune disease of the skin that affects 125 million people worldwide. This report benchmarks progress in Canada and countries across Europe since the 2014 World Health Organization (WHO) Resolution, which called for global action to improve quality of life for people living with the disease.1,2,3,4
The report, Encouraging policy action to address the psoriasis challenge, sponsored by Eli Lilly and Company, identifies psoriasis awareness, diagnosis, treatment and support as critical areas for improvement. Findings also highlight inequality in access to support and effective treatment for those living with psoriasis. The report details ways the psoriasis community can help meet this challenge and ease the burden on both patients and the healthcare system.1
Based upon insights from leading experts in academia, the medical profession, patients and patient associations across France, Germany, Italy, Spain, the UK and Canada, the report concludes that more government action is needed to address the challenges of psoriasis, including the negative physical and mental health strain of the disease, as well as the growing economic impact.1
Each country was benchmarked on the effectiveness of their psoriasis policies and guidelines, including adherence to WHO recommendations.1
We know that psoriasis management to a great extent depends on national healthcare systems. Some countries have well-established, well-functioning healthcare systems with adequate resources to help all patients. In other countries, this might not be the case. Thats why we strongly urge national governments to prioritize their healthcare system and set up a national advocacy plan on psoriasis. Steps like these are essential to start improving life quality for people with psoriasis across the world. Said Lars Ettarp, President of the International Federation of Psoriasis Associations IFPA.
Erin Huntington, VP of International Corporate Affairs at Lilly said: Despite the WHO calling for worldwide action in 2014, much more clearly needs to be done across Europe and Canada to improve quality of life for those affected by psoriasis. We hope that this new report will help draw attention to this debilitating condition, and encourage debate and action by policymakers, academics, medical practitioners and patient advocates. We look forward to playing our part.
- ENDS -
Notes to Editors:
About Psoriasis
Psoriasis is a chronic, immune disease that affects the skin. It occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis affects approximately 125 million people worldwide,4 approximately 20 percent of whom have moderate-to-severe plaque psoriasis.5 Psoriasis can occur on any part of the body and is associated with other serious health conditions, such as diabetes, heart disease and some cancers.5,6 The most common form of psoriasis, plaque psoriasis, appears as raised, red patches covered with a silvery white build-up of dead skin cells.5
About the report1
Encouraging policy action to address the psoriasis challenge is a report by The Economist Intelligence Unit (EIU), sponsored by Eli Lilly and Company. In August-October 2016, The EIU conducted interviews with 19 leading experts in academia, the medical profession, patients and patient associations, across France, Germany, Italy, Spain, the UK and Canada.
Methodology1
The countries in the report were assessed using a scorecard framework developed by The EIU. This framework assesses countries efforts to follow national or European recommendations to improve the care of people living with psoriasis. As a starting point, The EIU used psoriasis policy recommendations from the WHO and complemented them with data from other relevant sources to create an assessment framework. The framework scores countries on their level of support for people with psoriasis by considering policy across all the areas relevant to improving care for people living with psoriasis. These areas are: access to professional medical care; access to treatment; national patient registry for psoriasis; activities to build awareness; diagnosis, monitoring and treatment guidelines; measurement of clinical indicators; continuum of care; side-effects of treatment; patient-centred care; workforce capacity; education and training on disease; quality measures; coordinated and integrated care; individualized/personalized treatment; patient education; psychological support; discrimination; the role of patient associations and advocacy groups.
Read More
About the Economist Intelligence Unit (EIU)7
The Economist Intelligence Unit (EIU) is a world leader in research and analysis, with nearly 70 years experience. Part of The Economist Group, the sister company toThe Economist newspaper, their work is independent and impartial. More information can be found at http://www.eiu.com or http://www.twitter.com/theeiu.
About the International Federation of Psoriasis Associations8
The International Federation of Psoriasis Associations (IFPA) is a non-profit organization made up of national and regional psoriasis associations from around the world.
IFPA strives to be the global psoriasis advocacy organization. Its goals are to empower IFPAs members, improve living conditions for patients, raise awareness of psoriasis and psoriatic arthritis and cooperate with fellow stakeholders. Since its founding in 1971, IFPA has continuously sought to resolve the challenges facing the international psoriasis community.
About Eli Lilly and Company
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet peoples needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
AboutEli LillyCanada Inc.
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world's first commercially-available insulin. Lilly Canada now employs 598 people across the country, working in the areas of oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at http://www.lilly.ca.
References
1. Encouraging policy action to address the psoriasis challenge, http://www.eiu.com. March 2016. https://www.eiuperspectives.economist.com/healthcare/encouraging-policy-action-address-psoriasis-challenge-1. Accessed April 3, 2017.
2. WHO, WHA67.9 Resolution. Geneva, World Health Organization, 2014. http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf. Accessed January 11, 2017.
3. WHO, Global Report on Psoriasis. Geneva, World Health Organization, 2016. http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf. Accessed January 11, 2017.
4. The International Federation of Psoriasis Associations (IFPA). https://ifpa-pso.com/wp-content/uploads/2017/01/Brochure-Psoriasis-is-a-serious-disease-deserving-global-attention.pdf. Accessed February 3, 2017.
5. Menter A, Gottlieb A, Feldman SR, et al. (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826-50.
6. Chiesa F, et al. The risk of cancer in patients with psoriasis, JAMA Dermatology. 2016. 152(3) 282-290.
7. The Economist Intelligence Unit. Introduction. https://www.eiu.com/home.aspx. Accessed January 11, 2017.
8. The International Federation of Psoriasis Associations (IFPA). http://www.ifpa-pso.com/web/page.aspx?refid=10. Accessed January 11, 2017.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170418005712/en/
Go here to see the original:
Eli Lilly and Company: New Report Reveals Little Progress on 2014 WHO Psoriasis Recommendations - Yahoo Finance
Posted in Psoriasis
Comments Off on Eli Lilly and Company: New Report Reveals Little Progress on 2014 WHO Psoriasis Recommendations – Yahoo Finance
Medical CANNABIS could help ease the agony of psoriasis and … – The Sun
Posted: at 9:35 am
The drug was found to have anti-inflammatory properties that can beat the itch caused by the conditions
IT is already being tested totreat chronic pain, nausea and anorexia but now cannabis could be used to treat painful skin conditions too.
The drug contains anti-inflammatory properties that could help ease the pain of eczema, psoriasis and dermatitis, experts have discovered.
Alamy
And, even more promising for those who suffer with the conditions, it could prove successful at getting rid of the dreaded itch that comes with them.
Researchers fromUniversity of Colorado Anschutz Medical Campus found the active ingredient in cannabis, calledtetrahydrocannabinol (THC), successful in reducing inflammation and swelling in mice.
Tests also showed thatmice with melanoma saw their tumour growth slowed significantly when injected with THC but researchers warnedit was not yet a potential treatment for the disease.
The possible new treatment comes in the form of a cream that has anti-inflammatory properties from the cannabinoids.
Eight out of 21 patients who applied the cream twice a day for three weeks were completely free of itching afterwards
Robert Dellavalle, lead author and associate professor of dermatology at the university, said: Perhaps the most promising role for cannabinoids is in the treatment of itch.
These are topical cannabinoid drugs with little or no psychotropic effect that can be used for skin disease.
Psoriasis is a skin condition that causes red, flaky, crusty patches of skin covered with silvery scales.
These patches normally appear on your elbows, knees, scalp and lower back, but can appear anywhere on your body.
Most people are only affected with small patches. In some cases, the patches can be itchy or sore.
It affects around two per cent of the UK population.
Why does it happen?
People with psoriasis have an increased production of skin cells.
Skin cells are normally made and replaced every three to four weeks, but in psoriasis this process only lasts about three to seven days.
The resulting build-up of skin cells is what creates the patches associated with psoriasis.
It is thought to be a problem with the immune system and can run in families.
How is it treated?
Theres no cure for psoriasis, but a range of treatments can improve symptoms and the appearance of skin patches.
In most cases, the first treatment used will be a topical treatment, such as vitamin D analogues or topical corticosteroids.
Topical treatments are creams and ointments applied to the skin.
If these arent effective, or your condition is more severe, a treatment called phototherapy may be used.
Phototherapy involves exposing your skin to certain types of ultraviolet light.
In severe cases, where the above treatments are ineffective, systemic treatments may be used. These are oral or injected medicines that work throughout the whole body.
Source: NHS
Getty Images
Dr Dellavalle added that, although large-scale clinical trials of the treatment had not yet been done, the creams could provide an option for people who had tried other medications with no success.
He added: These diseases cause a lot of problems for people and have a direct impact on their quality of life.
The treatments are currently being bought over the internet and we need to educate dermatologists and patients about the potential uses of them.
We pay for your stories! Do you have a story for The Sun Online news team? Email us at tips@the-sun.co.uk or call 0207 782 4368
Continue reading here:
Medical CANNABIS could help ease the agony of psoriasis and ... - The Sun
Posted in Psoriasis
Comments Off on Medical CANNABIS could help ease the agony of psoriasis and … – The Sun
Synpromics Raises 5.2M of New Investment – Yahoo Finance
Posted: at 9:34 am
EDINBURGH, Scotland--(BUSINESS WIRE)--
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announcethat it has completed a financing round of 5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.
Synpromics has grown rapidly over the past two years as it expanded its portfolio of international customers. These include leading gene therapy companies and multinational technology corporations, most recently GE Healthcare.
The majority of the new investment will be used to further develop and exemplify Synpromics proprietary PromPT synthetic promoter design platform. PromPT enables the design of unique synthetic promoters which give precise control of gene function in many areas of gene medicine including gene therapy, cell therapy and gene editing. The Company is also preparing to move into a larger, new purpose built, facility.
David Venables, CEO of Synpromics, commented Since our last fundraising round 18 months ago the business has grown rapidly as weve signed more commercial partnerships with companies in the US and Europe. We see an exciting opportunity to fund further rapid expansion of our business, supported by our innovative science and novel capabilities.
Alexandra Lindsay, Investment Director at Calculus Capital, added We have been delighted with the progress which Synpromics has made since we made our first investment some 18 months ago. They have a very strong team and the technology has been clearly validated through partnerships with some of the worlds leading gene medicine companies.
Kerry Sharp, Head of the Scottish Investment Bank, said Having supported Synpromics from an early stage it is great to see the progress that has been achieved to develop and grow the business in the highly dynamic synthetic biology industry.We look forward to continuing to work with the company, both from an investment perspective and through our account management support, to deliver its long term growth ambition.
-Ends-
Notes to Editors
About Synpromics
Synpromics is a private company focused on commercialising its proprietary technology in the emerging field of synthetic biology by developing customised synthetic promoters. The company has partnership deals with a number of gene therapy companies including AGTC, Adverum, and uniQure, and bioprocessing companies such as GE Healthcare and Sartorius-Stedim Celca.
Synpromics technology gives biological researchers, developers and manufacturers unprecedented control of gene expression through the ability to create a comprehensive portfolio of man-made DNA regulatory sequences.
Synthetic promoters are DNA sequences that do not exist in nature and are designed to regulate the activity of genes, controlling a genes ability to produce its own uniquely encoded protein. Currently, the biotech industry largely relies on naturally occurring promoters to drive protein production. However, natural promoters have evolved for biological functions within the context of the organism in question, and as such they were not purpose-designed for industrial or therapeutic applications. The technology developed by Synpromics allows for the design of synthetic promoters that are optimally tailored to drive gene expression at the desired level and specificity. The technology platform facilitates the creation of a large collection of distinct and relevant synthetic promoters for a diverse array of applications
For more information see http://www.synpromics.com
About Calculus Capital
Calculus Capital is a specialist in creating and managing private equity funds for individuals. A pioneer in the Enterprise Investment Scheme (EIS) space, Calculus launched the UKs first HMRC-approved EIS fund in 1999 and has gone on to launch 16 further funds and four VCT offers. Calculus seeks capital appreciation from dynamic, established, private UK companies across a multitude of sectors. Calculus prefers to invest 2m-5m per company.As at January 2017 it had over 130m of funds under management.
Calculus Capitals experienced investment team, diligent investment process and hands on approach have resulted in an impressive track record of investment success. Calculus has won multiple awards including Best EIS Fund Manager at the Growth Investor Awards 2016 and the EIS Associations Fund Manager of the Year Award in 2016, 2015, 2014, 2011 and 2009.
Read More
Read the original post:
Synpromics Raises 5.2M of New Investment - Yahoo Finance
Posted in Gene Medicine
Comments Off on Synpromics Raises 5.2M of New Investment – Yahoo Finance